PL319511A1 - Parenteral pharmaceutic compositions containing gf120918a - Google Patents

Parenteral pharmaceutic compositions containing gf120918a

Info

Publication number
PL319511A1
PL319511A1 PL95319511A PL31951195A PL319511A1 PL 319511 A1 PL319511 A1 PL 319511A1 PL 95319511 A PL95319511 A PL 95319511A PL 31951195 A PL31951195 A PL 31951195A PL 319511 A1 PL319511 A1 PL 319511A1
Authority
PL
Poland
Prior art keywords
gf120918a
parenteral
compositions containing
pharmaceutic compositions
pharmaceutic
Prior art date
Application number
PL95319511A
Inventor
Wei-Qin Tong
Mickey Lee Wells
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of PL319511A1 publication Critical patent/PL319511A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL95319511A 1994-10-05 1995-10-04 Parenteral pharmaceutic compositions containing gf120918a PL319511A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31830894A 1994-10-05 1994-10-05
PCT/US1995/012952 WO1996011007A1 (en) 1994-10-05 1995-10-04 Parenteral pharmaceutical compositions containing gf120918a

Publications (1)

Publication Number Publication Date
PL319511A1 true PL319511A1 (en) 1997-08-18

Family

ID=23237614

Family Applications (1)

Application Number Title Priority Date Filing Date
PL95319511A PL319511A1 (en) 1994-10-05 1995-10-04 Parenteral pharmaceutic compositions containing gf120918a

Country Status (12)

Country Link
EP (1) EP0784474A2 (en)
JP (1) JPH10507177A (en)
KR (1) KR970705997A (en)
AU (1) AU702519B2 (en)
BR (1) BR9509251A (en)
CA (1) CA2201628A1 (en)
CZ (1) CZ104197A3 (en)
HU (1) HUT77883A (en)
NZ (1) NZ295546A (en)
PL (1) PL319511A1 (en)
RU (1) RU2157687C2 (en)
WO (1) WO1996011007A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9710612D0 (en) * 1997-05-23 1997-07-16 Glaxo Group Ltd Synthesis of acridine derivatives
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
US5922754A (en) * 1998-10-02 1999-07-13 Abbott Laboratories Pharmaceutical compositions containing paclitaxel
MA26696A1 (en) 1998-10-08 2004-12-20 Smithkline Beecham Plc NOVEL TETRAHYDROBENZAZEPINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AT408186B (en) * 1998-12-15 2001-09-25 Sanochemia Pharmazeutika Ag AQUEOUS PREPARATION OF BETA CAROTINE
DK1189637T3 (en) 1999-05-17 2006-12-11 Cancer Res Ventures Ltd Products to improve the bioavailability of orally administered drugs
US6521635B1 (en) 2000-01-20 2003-02-18 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of MXR transport by acridine derivatives
IL153676A0 (en) * 2000-06-30 2003-07-06 Inex Pharmaceuticals Corp Liposomal pharmaceutical compositions
WO2003002150A1 (en) * 2001-06-28 2003-01-09 Wyeth Composition and method for reducing adverse interactions between phenothiazine derivatives and plasma
KR100866728B1 (en) * 2004-11-12 2008-11-03 주식회사종근당 The injection of tacrolimus
FR2948568B1 (en) * 2009-07-30 2012-08-24 Sanofi Aventis PHARMACEUTICAL FORMULATION

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2783680B2 (en) * 1991-01-11 1998-08-06 ラボラトワール、グラクソ、ソシエテ、アノニム Acridine derivative

Also Published As

Publication number Publication date
CA2201628A1 (en) 1996-04-18
MX9702473A (en) 1997-07-31
JPH10507177A (en) 1998-07-14
WO1996011007A1 (en) 1996-04-18
NZ295546A (en) 1999-01-28
AU702519B2 (en) 1999-02-25
KR970705997A (en) 1997-11-03
CZ104197A3 (en) 1997-09-17
BR9509251A (en) 1997-10-21
RU2157687C2 (en) 2000-10-20
HUT77883A (en) 1998-09-28
EP0784474A2 (en) 1997-07-23
AU3891395A (en) 1996-05-02

Similar Documents

Publication Publication Date Title
PL316040A1 (en) Pharmaceutic compositions
PL336980A1 (en) Pharmaceutic composition
PL325598A1 (en) Deriphenacin containing pharmaceutic preparation
PL330223A1 (en) Pharmaceutic composition
PL328455A1 (en) Immunomodulating pharmaceutic composition
ZA957233B (en) Topically-effective compositions
GB9408545D0 (en) Compositions
PL324341A1 (en) Pharmaceutic compositions and compounds
ZA948348B (en) compositions containing piperine
AU6895694A (en) Bar screen having compound fine screen bar rack
PL325411A1 (en) Pharmaceutic preparation
PL324166A1 (en) Aromatic compounds and pharmaceutic compositions containing them
PL321859A1 (en) Pral compositions
PL319511A1 (en) Parenteral pharmaceutic compositions containing gf120918a
HRP980417B1 (en) Alatrofloxacin parenteral compositions
PL334006A1 (en) Lyophilisable pharmaceutic compositions
PL329919A1 (en) Diclophenac-based pharmaceutic compositions
PL336038A1 (en) Pharmaceutic compositions
PL331645A1 (en) Pharmaceutic composition containing 4-oxobutanic acids
GB9409543D0 (en) Compositions
GB9502770D0 (en) Amine-curable compositions
ZA954709B (en) Mineral-fiber compositions
GB2290299B (en) Anti-lubricant compositions
HU9502822D0 (en) Compositions containing difluormethoxi-2,2,2-trifluor-ethane
PL317526A1 (en) Pharmaceutic compounds